VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVOK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EVOKEvoke Pharma, Inc.
$11.00$19M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEVOKQuarterly Financials

Evoke Pharma, Inc. (EVOK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Evoke Pharma, Inc. (EVOK) quarterly income statement — complete revenue, gross profit & net income history

EVOK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue4.28M3.75M3.08M3.31M2.65M2.55M1.74M1.68M1.56M1.13M810.41K796.37K832.1K461.8K418.38K360.57K930.45K236.63K90.42K23.02K
Revenue Growth %61.4%47.06%77.48%97.4%69.83%125.51%114.15%110.45%87.82%144.99%93.7%120.86%-10.57%95.15%362.7%1466.34%----
Cost of Goods Sold101.98K167.68K41.61K118.5K104.02K41.48K92.53K59.02K34.91K57.36K50.59K190.08K89.78K67.77K22.76K136.68K58.44K68.25K64.75K86.71K
COGS % of Revenue2.38%4.47%1.35%3.58%3.92%1.63%5.33%3.52%2.23%5.07%6.24%23.87%10.79%14.68%5.44%37.91%6.28%28.84%71.61%376.68%
Gross Profit4.18M3.58M3.04M3.19M2.55M2.51M1.64M1.62M1.53M1.07M759.82K606.29K742.33K394.02K395.62K223.89K872.01K168.38K25.67K-63.69K
Gross Margin %97.62%95.53%98.65%96.42%96.08%98.37%94.67%96.48%97.77%94.93%93.76%76.13%89.21%85.32%94.56%62.09%93.72%71.16%28.39%-276.68%
Gross Profit Growth %63.99%42.81%84.94%97.27%66.9%133.69%116.23%166.7%105.83%172.58%92.06%170.79%-14.87%134%1441.18%451.52%----
Operating Expenses5.32M5.14M4.34M4.38M3.84M3.73M3.14M3.5M3.13M2.86M2.91M2.32M2.65M2.51M2.45M1.77M2.72M2.34M2.62M2.15M
OpEx % of Revenue124.18%137.08%140.91%132.5%144.52%146.33%181.17%209.12%200.36%252.65%359.69%290.83%319.06%542.81%584.83%491.23%291.99%987.76%2893.27%9319.7%
Selling, General & Admin5.31M5.13M4.3M4.38M3.82M3.73M3.14M3.48M3.13M2.77M2.85M2.29M2.61M2.32M2.41M1.74M2.64M2.14M2.34M2.04M
SG&A % of Revenue124.05%136.85%139.52%132.5%144.08%146.33%180.9%207.78%200.36%244.49%351.42%287.41%314.2%501.34%574.85%481.33%283.21%905.25%2586.01%8868.58%
Research & Development5.32K8.41K42.78K16.32B11.68K04.64K22.56K092.36K66.99K27.21K40.39K191.48K41.72K35.72K81.7K195.23K277.82K103.85K
R&D % of Revenue0.12%0.22%1.39%493353.79%0.44%-0.27%1.35%-8.16%8.27%3.42%4.85%41.46%9.97%9.91%8.78%82.5%307.26%451.11%
Other Operating Expenses000-1000K0000000000000000
Operating Income-1.14M-1.56M-1.3M-1.19M-1.29M-1.22M-1.5M-1.89M-1.6M-1.78M-2.16M-1.71M-1.91M-2.11M-2.05M-1.55M-1.84M-2.17M-2.59M-2.21M
Operating Margin %-26.56%-41.55%-42.26%-36.08%-48.44%-47.96%-86.5%-112.64%-102.6%-157.72%-265.93%-214.7%-229.85%-457.48%-490.27%-429.14%-198.27%-916.6%-2864.88%-9596.38%
Operating Income Growth %11.51%-27.4%13.29%36.77%19.82%31.43%30.34%-10.42%16.16%15.54%-5.07%-10.5%-3.67%2.6%20.82%29.95%11.29%68.86%-44.42%-55.12%
EBITDA-1.03M-1.45M-1.18M-1.07M-1.19M-1.14M-1.46M000-2.12M-1.68M0-2.11M-2.05M00000
EBITDA Margin %-24.05%-38.55%-38.4%-32.24%-44.7%-44.78%-83.85%----261.57%-210.6%--456.64%-490.08%-----
EBITDA Growth %13.16%-26.59%18.71%---31.35%100%-100%-3.38%---------
D&A (Non-Cash Add-back)00000001.89M1.6M1.78M001.91M001.55M1.84M2.17M2.59M2.21M
EBIT-1.03M-1.45M-1.18M-1.07M-1.19M-1.14M-1.46M-1.86M-1.57M-1.74M-2.12M-1.68M-1.89M-2.11M-2.05M-1.55M-1.84M-2.17M-2.48M-2.21M
Net Interest Income-18.52K-12.12K-4.43K932-26.73K-43.66K-78.6K-99.48K-90.47K-83.49K-87.96K-93.44K-101.31K-120.75K-122.49K-125.01K-124.61K-121.65K-120.17K-58.78K
Interest Income107.51K112.53K118.85K126.96K99.29K81K46.06K26.54K35.56K41.16K35.33K32.59K24.71K3.91K7951.02K1.42K3.01K3.16K776
Interest Expense126.03K124.66K123.29K126.03K126.03K124.66K124.66K126.03K126.03K124.66K123.29K126.03K126.03K124.66K123.29K126.03K126.03K124.66K123.34K59.55K
Other Income/Expense-18.52K-12.12K-4.43K932-26.73K-43.66K-78.6K-99.48K-90.47K-83.49K-87.96K-93.44K-101.31K-120.75K-122.49K-125.01K-124.61K-121.65K-15.04K-58.78K
Pretax Income-1.16M-1.57M-1.31M-1.19M-1.31M-1.27M-1.58M-1.99M-1.69M-1.87M-2.24M-1.8M-2.01M-2.23M-2.17M-1.67M-1.97M-2.29M-2.61M-2.27M
Pretax Margin %-26.99%-41.87%-42.41%-36.05%-49.45%-49.67%-91.03%-118.58%-108.39%-165.1%-276.78%-226.43%-242.02%-483.63%-519.54%-463.81%-211.67%-968.01%-2881.52%-9851.7%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.16M-1.57M-1.31M-1.19M-1.31M-1.27M-1.58M-1.99M-1.69M-1.87M-2.24M-1.8M-2.01M-2.23M-2.17M-1.67M-1.97M-2.29M-2.61M-2.27M
Net Margin %-26.99%-41.87%-42.41%-36.05%-49.45%-49.67%-91.03%-118.58%-108.39%-165.1%-276.78%-226.43%-242.02%-483.63%-519.54%-463.81%-211.67%-968.01%-2881.52%-9851.7%
Net Income Growth %11.9%-23.97%17.32%39.98%22.52%32.16%29.57%-10.21%15.89%16.36%-3.19%-7.82%-2.25%2.5%16.57%26.26%7.5%67.12%-45.53%-59.91%
Net Income (Continuing)-1.16M-1.57M-1.31M-1.19M-1.31M-1.27M-1.58M-1.99M-1.69M-1.87M-2.24M-1.8M-2.01M-2.23M-2.17M-1.67M-1.97M-2.29M-2.61M-2.27M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.45-0.62-0.51-0.80-0.94-0.93-2.09-7.13-6.08-6.70-8.81-6.36-7.23-8.47-9.55-7.37-8.71-10.19-12.04-12.27
EPS Growth %52.13%33.33%75.6%88.78%84.54%86.12%76.28%-12.11%15.91%20.9%7.75%13.7%16.99%16.88%20.68%39.93%25.75%74.62%-14.12%-46.07%
EPS (Basic)-0.45-0.62-0.51-0.80-0.94-0.93-2.09-7.13-6.08-6.70-8.81-6.36-7.23-8.47-9.55-7.37-8.71-10.19-12.04-12.27
Diluted Shares Outstanding2.56M2.55M2.55M1.49M1.4M1.36M756.81K278.59K278.59K278.59K278.59K278.59K278.59K263.08K227.62K226.78K225.99K224.9K216.38K184.87K
Basic Shares Outstanding2.56M2.55M2.55M1.49M1.4M1.36M756.81K278.59K278.59K278.59K278.59K278.59K278.59K263.08K227.62K226.78K225.99K224.9K216.38K184.87K
Dividend Payout Ratio--------------------